If you have atypical hemolytic uremic syndrome (aHUS) and are working, you may want to consider speaking with your employer about your disease. Here are some things to help you decide what is best for you to do. What is aHUS? aHUS is characterized by low levels of circulating…
Health Insights
Shoshin for aHUS Patients
If you are living with a chronic disease such as atypical hemolytic uremic syndrome (aHUS), a concept called shoshin may help to change your perspective, allowing you see the world, and your disorder, in a different light. What is shoshin? The word shoshin comes from Zen Buddhism, and means “beginner’s…
About OneSource for aHUS Patients
If you have atypical hemolytic uremic syndrome (aHUS) and are being treated with Soliris (eculizumab) or Ultomiris (ravulizumab-cwvz), you may wish to consider enrolling in OneSource, a complimentary and personalized patient support program by Alexion, the therapies’ manufacturer. What is aHUS? aHUS is a rare multi-organ disorder…
Importance of Advocacy for aHUS
Atypical hemolytic uremic syndrome (aHUS) is a rare disease that is sometimes hard to diagnose. Health advocacy works to raise awareness about aHUS, Â helping to ensure patients are given a faster and accurate diagnosis, treatment options, and ultimately, better medical care. Here is information about advocacy and organizations that advocate…
aHUS and Cancer
People with atypical hemolytic uremic syndrome (aHUS) usually have a genetic predisposition for disorders of the complement system. However, aHUS usually develops only following a triggering factor such as an infection, pregnancy, certain medications, or cancer. Following is more information about the relationship between aHUS and…
Treatment Team of Specialists for aHUS
Atypical hemolytic uremic syndrome (aHUS) primarily affects the kidneys but it can also affect numerous other organs in the body — what doctors sometimes call extra-renal manifestations. To better diagnose and treat these symptoms, a multidisciplinary team of specialists may be necessary. If you’ve been diagnosed with aHUS, here…
Paramedical Services for aHUS
Patients with atypical hemolytic uremic syndrome (aHUS) and their family members may benefit from paramedical services — those offered by therapists, dieticians, and social workers, among others. Here is further information on paramedical services and a listing of some which may be of help. What are paramedical services? Paramedical…
Individualized Education Plan (IEP) for aHUS Patients
Atypical hemolytic uremic syndrome (aHUS) affects an estimated 1 in 500,000 people in the U.S. Almost half, between 42% and 47%, of these people are diagnosed before age 18. Children with aHUS may experience disease-related difficulties at school that affect their ability to learn. An individualized education…
aHUS Triggers
Atypical hemolytic uremic syndrome (aHUS), a chronic multi-organ disease that primarily affects kidney function, may be caused by a genetic mutation coupled with a triggering event. Because aHUS can lead to tissue damage, anemia, and a high risk of bleeding and bruising, it’s important to understand more about the triggers…
aHUS in Children
Atypical hemolytic uremic syndrome (aHUS) can occur during childhood and at any time thereafter. Here is more information about how aHUS may affect children. What is aHUS? aHUS is a chronic disease where small blood clots form in multiple organs of the body, especially in the kidneys. The blood clots…
Recent Posts
- Team care saves mother with trio of postpartum complications
- Once a good side hustle, donating plasma is now too risky for me
- Treatment halts aHUS recurrence after COVID-triggered relapse
- For women like me, hair loss can be particularly devastating
- aHUS drugs restore kidney function in 60% of patients in Romania
- aHUS has changed my life in drastic and unexpected ways
- Rare lupus nephritis–aHUS case improves after Soliris treatment
- How my young children had to adapt to having a sick parent
- Early Soliris use boosts kidney recovery, cuts dialysis need in aHUS
- Dual therapy benefits man with aHUS, Castleman disease